ABT logo

Abbott Laboratories (ABT) Selling, General & Administrative Expenses

Annual SG&A

$10.95 B
-$299.00 M-2.66%

31 December 2023

ABT Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$2.90 B
-$41.00 M-1.40%

30 September 2024

ABT Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

$152.97 B
+$2.14 B+1.42%

30 September 2024

ABT TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABT Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2.7%+6.3%+1266.1%
3 y3 years+12.9%+4.6%+1310.4%
5 y5 years+12.4%+18.6%+1475.3%

ABT Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-3.3%+12.9%-5.0%+6.3%at high+32.2%
5 y5 years-3.3%+12.9%-5.0%+27.2%at high+53.5%
alltimeall time-3.3%+1170.0%-31.7%+216.4%at high+9164.5%

Abbott Laboratories Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.90 B(-1.4%)
$11.51 B(+1.5%)
June 2024
-
$2.94 B(-0.8%)
$11.34 B(+1.8%)
Mar 2024
-
$2.96 B(+8.6%)
$11.15 B(+1.8%)
Dec 2023
$10.95 B(-2.7%)
$2.72 B(+0.0%)
$10.95 B(-2.2%)
Sept 2023
-
$2.72 B(-0.6%)
$11.20 B(-0.1%)
June 2023
-
$2.74 B(-0.8%)
$11.21 B(-0.2%)
Mar 2023
-
$2.76 B(-7.1%)
$11.22 B(-0.2%)
Dec 2022
$11.25 B(-0.7%)
$2.97 B(+8.9%)
$11.25 B(-0.7%)
Sept 2022
-
$2.73 B(-0.9%)
$11.32 B(-0.3%)
June 2022
-
$2.76 B(-1.1%)
$11.36 B(+0.3%)
Mar 2022
-
$2.79 B(-8.6%)
$11.33 B(+0.0%)
Dec 2021
$11.32 B(+16.8%)
$3.05 B(+10.2%)
$11.32 B(+4.4%)
Sept 2021
-
$2.77 B(+1.5%)
$10.85 B(+4.5%)
June 2021
-
$2.73 B(-2.0%)
$10.38 B(+4.5%)
Mar 2021
-
$2.78 B(+8.3%)
$9.93 B(+2.4%)
Dec 2020
$9.70 B(-0.7%)
$2.57 B(+11.6%)
$9.70 B(+1.6%)
Sept 2020
-
$2.30 B(+1.1%)
$9.54 B(-1.4%)
June 2020
-
$2.28 B(-10.7%)
$9.68 B(-1.6%)
Mar 2020
-
$2.55 B(+5.6%)
$9.84 B(+0.7%)
Dec 2019
$9.77 B(+0.2%)
$2.41 B(-1.1%)
$9.77 B(+0.6%)
Sept 2019
-
$2.44 B(+0.2%)
$9.71 B(+0.7%)
June 2019
-
$2.43 B(-1.8%)
$9.65 B(-0.3%)
Mar 2019
-
$2.48 B(+5.0%)
$9.68 B(-0.7%)
Dec 2018
$9.74 B(+6.1%)
$2.36 B(-0.8%)
$9.74 B(-1.2%)
Sept 2018
-
$2.38 B(-3.6%)
$9.86 B(+2.7%)
June 2018
-
$2.47 B(-3.0%)
$9.60 B(+3.4%)
Mar 2018
-
$2.54 B(+2.6%)
$9.28 B(+1.1%)
Dec 2017
$9.18 B(+36.3%)
$2.48 B(+17.1%)
$9.18 B(+9.6%)
Sept 2017
-
$2.12 B(-1.6%)
$8.38 B(+6.2%)
June 2017
-
$2.15 B(-11.9%)
$7.89 B(+5.5%)
Mar 2017
-
$2.44 B(+45.8%)
$7.48 B(+11.0%)
Dec 2016
$6.74 B(-0.7%)
$1.67 B(+2.8%)
$6.74 B(+0.3%)
Sept 2016
-
$1.63 B(-6.3%)
$6.72 B(-0.6%)
June 2016
-
$1.74 B(+2.3%)
$6.76 B(+0.1%)
Mar 2016
-
$1.70 B(+2.6%)
$6.75 B(-0.6%)
Dec 2015
$6.79 B(+3.9%)
$1.66 B(-0.7%)
$6.79 B(-0.2%)
Sept 2015
-
$1.67 B(-3.5%)
$6.80 B(+1.1%)
June 2015
-
$1.73 B(-0.6%)
$6.72 B(+1.2%)
Mar 2015
-
$1.74 B(+4.3%)
$6.65 B(+1.8%)
Dec 2014
$6.53 B(+2.5%)
$1.67 B(+4.5%)
$6.53 B(+2.0%)
Sept 2014
-
$1.59 B(-3.3%)
$6.41 B(-0.3%)
June 2014
-
$1.65 B(+1.8%)
$6.42 B(-1.0%)
Mar 2014
-
$1.62 B(+5.1%)
$6.49 B(-2.5%)
Dec 2013
$6.37 B(-5.4%)
$1.54 B(-4.4%)
$6.65 B(+6.1%)
Sept 2013
-
$1.61 B(-6.0%)
$6.27 B(-4.7%)
June 2013
-
$1.71 B(-4.0%)
$6.58 B(-1.5%)
Mar 2013
-
$1.79 B(+54.2%)
$6.68 B(-0.8%)
Dec 2012
$6.74 B(-8.6%)
$1.16 B(-39.7%)
$6.73 B(+118.0%)
Sept 2012
-
$1.92 B(+5.9%)
$3.09 B(-42.9%)
June 2012
-
$1.81 B(-1.5%)
$5.41 B(-14.9%)
Mar 2012
-
$1.84 B(-174.1%)
$6.36 B(-13.7%)
Dec 2011
$7.37 B(-29.0%)
-$2.49 B(-158.7%)
$7.37 B(-41.8%)
Sept 2011
-
$4.24 B(+53.5%)
$12.65 B(+14.1%)
June 2011
-
$2.76 B(-3.1%)
$11.08 B(+0.2%)
Mar 2011
-
$2.85 B(+1.9%)
$11.06 B(+6.6%)
Dec 2010
$10.38 B(+23.4%)
$2.80 B(+4.6%)
$10.38 B(+5.8%)
Sept 2010
-
$2.67 B(-2.6%)
$9.80 B(+6.4%)
June 2010
-
$2.74 B(+26.9%)
$9.22 B(+8.5%)
Mar 2010
-
$2.16 B(-2.8%)
$8.50 B(+1.1%)
Dec 2009
$8.41 B(-0.4%)
$2.23 B(+6.7%)
$8.41 B(-0.9%)
Sept 2009
-
$2.09 B(+3.0%)
$8.48 B(+0.2%)
June 2009
-
$2.02 B(-2.3%)
$8.46 B(-0.3%)
Mar 2009
-
$2.07 B(-9.9%)
$8.49 B(+0.6%)
Dec 2008
$8.44 B(+13.9%)
$2.30 B(+11.1%)
$8.44 B(+5.2%)
Sept 2008
-
$2.07 B(+0.8%)
$8.02 B(+1.6%)
June 2008
-
$2.05 B(+1.7%)
$7.90 B(+3.3%)
Mar 2008
-
$2.02 B(+7.4%)
$7.64 B(+3.1%)
Dec 2007
$7.41 B(+16.7%)
$1.88 B(-3.4%)
$7.41 B(+2.4%)
Sept 2007
-
$1.95 B(+8.3%)
$7.23 B(+4.1%)
June 2007
-
$1.80 B(+0.5%)
$6.95 B(+4.1%)
Mar 2007
-
$1.79 B(+4.9%)
$6.67 B(+7.2%)
Dec 2006
$6.35 B
$1.70 B(+2.5%)
$6.22 B(+4.3%)
DateAnnualQuarterlyTTM
Sept 2006
-
$1.66 B(+9.3%)
$5.97 B(+4.4%)
June 2006
-
$1.52 B(+13.5%)
$5.72 B(+3.0%)
Mar 2006
-
$1.34 B(-7.4%)
$5.55 B(+0.9%)
Dec 2005
$5.50 B(+11.7%)
$1.45 B(+2.6%)
$5.50 B(+1.1%)
Sept 2005
-
$1.41 B(+4.3%)
$5.44 B(+5.1%)
June 2005
-
$1.35 B(+5.0%)
$5.17 B(+2.3%)
Mar 2005
-
$1.29 B(-7.2%)
$5.06 B(+2.7%)
Dec 2004
$4.92 B(+2.4%)
$1.39 B(+21.2%)
$4.92 B(+3.8%)
Sept 2004
-
$1.14 B(-7.5%)
$4.74 B(+2.5%)
June 2004
-
$1.24 B(+7.3%)
$4.63 B(-7.9%)
Mar 2004
-
$1.15 B(-4.7%)
$5.02 B(+3.2%)
Dec 2003
$4.81 B(+29.1%)
$1.21 B(+17.7%)
$4.86 B(+7.1%)
Sept 2003
-
$1.03 B(-37.0%)
$4.54 B(+1.4%)
June 2003
-
$1.63 B(+63.8%)
$4.48 B(+17.1%)
Mar 2003
-
$996.21 M(+12.2%)
$3.83 B(+2.8%)
Dec 2002
$3.72 B(-0.3%)
$887.94 M(-8.2%)
$3.72 B(-4.0%)
Sept 2002
-
$967.22 M(-1.1%)
$3.88 B(-0.7%)
June 2002
-
$978.01 M(+9.7%)
$3.91 B(+0.8%)
Mar 2002
-
$891.69 M(-14.6%)
$3.88 B(+3.9%)
Dec 2001
$3.73 B(+29.0%)
$1.04 B(+5.0%)
$3.73 B(+9.0%)
Sept 2001
-
$995.09 M(+4.9%)
$3.43 B(+9.5%)
June 2001
-
$948.20 M(+26.9%)
$3.13 B(+7.5%)
Mar 2001
-
$747.01 M(+1.5%)
$2.91 B(+0.6%)
Dec 2000
$2.89 B(+1.3%)
$735.65 M(+5.2%)
$2.89 B(-1.8%)
Sept 2000
-
$699.28 M(-4.1%)
$2.95 B(+0.3%)
June 2000
-
$728.94 M(-0.2%)
$2.94 B(+1.2%)
Mar 2000
-
$730.30 M(-7.3%)
$2.90 B(+1.6%)
Dec 1999
$2.86 B(+3.5%)
$788.13 M(+14.3%)
$2.86 B(+2.1%)
Sept 1999
-
$689.82 M(-0.6%)
$2.80 B(+0.9%)
June 1999
-
$693.70 M(+1.2%)
$2.77 B(+0.4%)
Mar 1999
-
$685.48 M(-6.1%)
$2.76 B(+0.1%)
Dec 1998
$2.76 B(+2.4%)
$730.30 M(+9.8%)
$2.76 B(+0.6%)
Sept 1998
-
$665.20 M(-2.5%)
$2.74 B(-0.4%)
June 1998
-
$682.16 M(-0.0%)
$2.75 B(+1.1%)
Mar 1998
-
$682.20 M(-4.3%)
$2.72 B(+0.9%)
Dec 1997
$2.70 B(+9.6%)
$713.10 M(+5.6%)
$2.70 B(+1.5%)
Sept 1997
-
$675.10 M(+3.7%)
$2.66 B(+2.3%)
June 1997
-
$651.00 M(-0.9%)
$2.60 B(+2.0%)
Mar 1997
-
$656.60 M(-2.5%)
$2.54 B(+3.4%)
Dec 1996
$2.46 B(+10.3%)
$673.12 M(+9.4%)
$2.46 B(+4.0%)
Sept 1996
-
$615.27 M(+2.7%)
$2.36 B(+4.1%)
June 1996
-
$598.90 M(+4.6%)
$2.27 B(+3.0%)
Mar 1996
-
$572.40 M(-0.9%)
$2.20 B(-1.2%)
Dec 1995
$2.23 B(+8.6%)
$577.88 M(+10.8%)
$2.23 B(+0.2%)
Sept 1995
-
$521.75 M(-2.0%)
$2.23 B(+0.3%)
June 1995
-
$532.28 M(-11.1%)
$2.22 B(+2.9%)
Mar 1995
-
$598.83 M(+4.5%)
$2.16 B(+4.9%)
Dec 1994
$2.05 B(+3.3%)
$572.96 M(+11.1%)
$2.05 B(+53.7%)
Sept 1994
-
$515.57 M(+10.0%)
$1.34 B(-12.0%)
June 1994
-
$468.74 M(-5.7%)
$1.52 B(-16.4%)
Mar 1994
-
$497.18 M(-444.3%)
$1.82 B(-8.5%)
Dec 1993
$1.99 B(-29.5%)
-$144.42 M(-120.7%)
$1.99 B(-30.4%)
Sept 1993
-
$698.10 M(-9.1%)
$2.86 B(+2.3%)
June 1993
-
$767.60 M(+15.1%)
$2.79 B(-2.7%)
Mar 1993
-
$666.90 M(-7.8%)
$2.87 B(+1.7%)
Dec 1992
$2.82 B(+29.4%)
$723.20 M(+14.3%)
$2.82 B(+4.9%)
Sept 1992
-
$632.90 M(-25.1%)
$2.69 B(+3.8%)
June 1992
-
$844.50 M(+36.2%)
$2.59 B(+13.5%)
Mar 1992
-
$620.00 M(+4.9%)
$2.28 B(+4.7%)
Dec 1991
$2.18 B(+18.3%)
$591.00 M(+10.7%)
$2.18 B(+4.4%)
Sept 1991
-
$534.10 M(-0.4%)
$2.09 B(+3.6%)
June 1991
-
$536.20 M(+3.5%)
$2.02 B(+4.1%)
Mar 1991
-
$518.30 M(+3.7%)
$1.94 B(+5.0%)
Dec 1990
$1.84 B(+15.0%)
$500.00 M(+8.5%)
$1.84 B(+37.2%)
Sept 1990
-
$460.90 M(+1.1%)
$1.34 B(+52.3%)
June 1990
-
$456.00 M(+7.1%)
$881.60 M(+107.1%)
Mar 1990
-
$425.60 M
$425.60 M
Dec 1989
$1.60 B(+8.1%)
-
-
Dec 1988
$1.48 B(+15.7%)
-
-
Dec 1987
$1.28 B(+20.7%)
-
-
Dec 1986
$1.06 B(+14.3%)
-
-
Dec 1985
$928.20 M(+7.7%)
-
-
Dec 1984
$862.10 M
-
-

FAQ

  • What is Abbott Laboratories annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Abbott Laboratories?
  • What is Abbott Laboratories annual SG&A year-on-year change?
  • What is Abbott Laboratories quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Abbott Laboratories?
  • What is Abbott Laboratories quarterly SG&A year-on-year change?
  • What is Abbott Laboratories TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Abbott Laboratories?
  • What is Abbott Laboratories TTM SG&A year-on-year change?

What is Abbott Laboratories annual selling, general & administrative expenses?

The current annual SG&A of ABT is $10.95 B

What is the all time high annual SG&A for Abbott Laboratories?

Abbott Laboratories all-time high annual selling, general & administrative expenses is $11.32 B

What is Abbott Laboratories annual SG&A year-on-year change?

Over the past year, ABT annual selling, general & administrative expenses has changed by -$299.00 M (-2.66%)

What is Abbott Laboratories quarterly selling, general & administrative expenses?

The current quarterly SG&A of ABT is $2.90 B

What is the all time high quarterly SG&A for Abbott Laboratories?

Abbott Laboratories all-time high quarterly selling, general & administrative expenses is $4.24 B

What is Abbott Laboratories quarterly SG&A year-on-year change?

Over the past year, ABT quarterly selling, general & administrative expenses has changed by +$172.00 M (+6.32%)

What is Abbott Laboratories TTM selling, general & administrative expenses?

The current TTM SG&A of ABT is $152.97 B

What is the all time high TTM SG&A for Abbott Laboratories?

Abbott Laboratories all-time high TTM selling, general & administrative expenses is $12.65 B

What is Abbott Laboratories TTM SG&A year-on-year change?

Over the past year, ABT TTM selling, general & administrative expenses has changed by +$141.78 B (+1266.09%)